The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study-Reference-Cited by-同舟云学术

The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study

Published:2018-03-27 Issue:1 Volume:18 Page:
ISSN:1471-244X
Container-title:BMC Psychiatry
language:en
Short-container-title:BMC Psychiatry

Author:

Hammoudeh Samer,Ghuloum Suhaila,Mahfoud Ziyad,Yehya Arij,Abdulhakam Abdulmoneim,Al-Mujalli Azza,Al-Zirie Mahmoud,Abdel Rahman Mohamed Osman,Godwin Angela,Younes Noura,Hani Yahya,Mook-Kanamori Dennis,Mook-Kanamori Marjonneke,El Sherbiny Reem,Al-Amin Hassen

Funder

Qatar National Research Fund

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1186/s12888-018-1662-6.pdf

Reference43 articles.

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120(16):1640–5.

2. Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry. 2015;14(3):339–47.

3. Grover SNN, Padmavati R, Chadda R, Tirupati S, Pallava A. Metabolic syndrome in antipsychotic naiive patients with schizophrenia: pooled analysis of data from three Indian studies. Early Interv Psychiatry. 2014;9(5):357–62.